A detailed history of State Board Of Administration Of Florida Retirement System transactions in Vir Biotechnology, Inc. stock. As of the latest transaction made, State Board Of Administration Of Florida Retirement System holds 23,932 shares of VIR stock, worth $254,397. This represents 0.0% of its overall portfolio holdings.

Number of Shares
23,932
Previous 23,932 -0.0%
Holding current value
$254,397
Previous $212,000 15.57%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

BUY
$7.63 - $12.66 $4,120 - $6,836
540 Added 2.31%
23,932 $212,000
Q1 2024

May 08, 2024

SELL
$8.6 - $11.9 $4,644 - $6,426
-540 Reduced 2.26%
23,392 $236,000
Q3 2023

Nov 08, 2023

BUY
$9.14 - $24.62 $1,462 - $3,939
160 Added 0.67%
23,932 $224,000
Q2 2023

Aug 11, 2023

BUY
$23.2 - $27.29 $8,816 - $10,370
380 Added 1.62%
23,772 $583,000
Q2 2022

Aug 05, 2022

BUY
$19.08 - $26.7 $190 - $267
10 Added 0.04%
23,392 $596,000
Q4 2021

Feb 08, 2022

SELL
$30.97 - $54.03 $296,135 - $516,634
-9,562 Reduced 29.03%
23,382 $979,000
Q3 2021

Nov 08, 2021

BUY
$34.9 - $54.54 $331,096 - $517,420
9,487 Added 40.44%
32,944 $1.43 Million
Q2 2021

Aug 10, 2021

BUY
$38.75 - $51.0 $92,457 - $121,686
2,386 Added 11.32%
23,457 $1.11 Million
Q1 2021

May 10, 2021

SELL
$26.34 - $83.07 $29,764 - $93,869
-1,130 Reduced 5.09%
21,071 $1.08 Million
Q4 2020

Feb 08, 2021

SELL
$25.51 - $43.38 $4,081 - $6,940
-160 Reduced 0.72%
22,201 $595,000
Q3 2020

Nov 09, 2020

BUY
$28.28 - $53.6 $99,262 - $188,136
3,510 Added 18.62%
22,361 $768,000
Q2 2020

Aug 07, 2020

BUY
$27.89 - $47.86 $525,754 - $902,208
18,851 New
18,851 $772,000

Others Institutions Holding VIR

About Vir Biotechnology, Inc.


  • Ticker VIR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 132,638,000
  • Market Cap $1.41B
  • Description
  • Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...
More about VIR
Track This Portfolio

Track State Board Of Administration Of Florida Retirement System Portfolio

Follow State Board Of Administration Of Florida Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Board Of Administration Of Florida Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on State Board Of Administration Of Florida Retirement System with notifications on news.